Koor Corporate Venture Capital
13
22M
8
0.17
1
0.38
6
- Stages of investment
- Areas of investment
Summary
Koor Corporate Venture Capital is the famous VC, which was founded in 1944. The company was established in Asia in Israel. Koor Corporate Venture Capital appeared to be a CVC structure as part of the corporation. The leading representative office of defined VC is situated in the Tel Aviv.
The real fund results show that this VC is 5 percentage points less often commits exit comparing to other companies. This Koor Corporate Venture Capital works on 17 percentage points more the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2006. The fund is generally included in less than 2 deals every year. The typical startup value when the investment from Koor Corporate Venture Capital is 10-50 millions dollars. The important activity for fund was in 2001.
The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Mysticom, Telespree, Followap For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Telecommunications, Enterprise Software.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Koor Corporate Venture Capital, startups are often financed by Star Ventures, Israel Corp, Viola Ventures. The meaningful sponsors for the fund in investment in the same round are Viola Ventures, Star Ventures, Pitango Venture Capital. In the next rounds fund is usually obtained by Viola Ventures, Pitango Venture Capital, Star Ventures.
We also calculated 1 valuable employee in our database.
Investments analytics
Analytics
- Total investments
- 13
- Lead investments
- 1
- Exits
- 6
- Rounds per year
- 0.17
- Follow on index
- 0.38
- Investments by industry
- Telecommunications (6)
- Wireless (5)
- Messaging (4)
- Manufacturing (3)
- Enterprise Software (3) Show 16 more
- Investments by region
-
- United States (8)
- United Kingdom (4)
- Israel (1)
- Peak activity year
- 2001
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Avg. valuation at time of investment
- 37M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 0.77
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Aevi Genomic Medicine | 22 Jun 2001 | Biotechnology, Health Care, Life Science, Biopharma | Early Stage Venture | 7M | United States, Pennsylvania, Radnor Township |
Proficiency | 10 Jun 2001 | Information Services, Enterprise Software, Manufacturing | Late Stage Venture | 27M | United States, Massachusetts, Marlborough |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.